Data / Form D filings / SteadySleep Rx Co.
SteadySleep Rx Co.: Form D filing
SteadySleep Rx Co., a pharmaceuticals company in Louisville, CO, filed a Form D with the SEC in 2010. The latest, on November 12, 2010, reports $800,000 sold of a $800,000 offering to 3 investors.
Find out what SteadySleep Rx Co. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 901 FRONT ST., SUITE 201, Louisville, CO, 80027
- Phone
- (720) 890-7716
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2007
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1505346
The full lists. Form D filings in Colorado: 1,787 rows, $89.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 12, 2010 | New notice | $800,000 | $800,000 | $0 | 3 | Oct 29, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kenneth W. Cohen | Director | |
| David W. Carley | Executive Officer, Director | |
| Kathryn B. Hyer | Executive Officer, Director | |
| Peter W. Letendre | Executive Officer, Director | |
| Bruce N. Barron | Director |
Every Form D from the week of Nov 8, 2010 · All recent filings in Colorado · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what SteadySleep Rx Co. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.